Lectures of Distinction - Series 2 Lectures of Distinction - Series 2 The second season of BOFAS LoD is starting September 2021 01 September 2021 The second series of BOFAS Lectures of Distinction is starting September 2021. The first lecture is on Principles of Ankle Fractures and will be held on Monday the 6th of September. Click here for more details and to register. Read more
Annual Meeting 2021 - Recap Annual Meeting 2021 - Recap The 2021 Annual Meeting is over, but click here if you missed it! 12 March 2021 We hope you enjoyed the 2021 Virtual Annual meeting, but if you could not make it, it's available for members free of charge! Follow the link to view the programme and recordings. Read more
New Website New Website We have a brand new look 01 February 2021 BOFAS are pleased to announce our new website! Read more
2Oct2025 BOFAS Principles Course - Dubai 02/10/2025 - 04/10/2025 Read more The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery. There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab. This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area. Venue - Le Meridien, Dubai, United Arab Emirates Documents to download ACv3BOFAS-Principles-Course-Programme-DXB(.pdf, 2.13 MB) - 534 download(s) Read more
20Oct2025 BOFAS Principles Course Taunton 20/10/2025 - 21/10/2025 Read more These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023. Venue - Taunton (TBC) Documents to download BOFAS-Course-Programme--Taunton-2025(.docx, 31.88 KB) - 768 download(s) Read more
Togay Koç / 08 July 2022 / Categories: Abstracts, 2015, Podium Metallic hemiarthroplasty for the treatment of end stage hallux rigidus: mid-term implant survival, functional outcome and cost analysis G. Dall, N. Clement, D. McDonald, I. Ahmed, A. Duckworth, H. Shalaby, J. McKinley Introduction: We present a review of 97 consecutive BioPro® metallic hemiarthroplasties performed in 80 patients for end-stage hallux rigidus, with a minimum of five years follow-up. Results: The mean age of the cohort was 55 (22 to 74) years. No patient was lost to follow-up. There were 15 revisions performed, one for infection, two for osteolysis, and 12 for pain. The all cause survival rate at five years was 85.6% (95% confidence interval (CI) 83.5 to 87.9). Younger age was a significant predictor of revision (odds ratio 1.09, 95% CI 1.02 to 1.17, p=0.014) on excluding infection and adjusting for confounding variables (Cox regression). Significant improvements were demonstrated at 5 years in the Manchester Oxford foot questionnaire (13.9, 95% CI 10.5 to 17.2) and in the physical component of the short form 12 score (6.5, 95% CI 4.1 to 8.9). The overall satisfaction rate was 72%. The cost per quality-adjusted-life-year at 5 years, accounting for a 3% per year revision rate, was £3,714. Conclusion: The BioPro offers good short to mid-term functional outcome and is a cost effective intervention. The relative high revision rate is associated with younger age and the use of this implant may be limited to older patients. Print 614 Tags: Hallux Rigidus